ArticleFrontiers in aging neuroscience2025
Integrated bioinformatics analysis reveals Netrin-1 as a key molecular link between Parkinson's disease and heart failure.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parkinson's disease (PD) patients face a higher risk of developing heart failure (HF). The objective of the study was to investigate the hub genes and potential mechanisms linking Parkinson's disease (PD) to heart failure (HF) using multiple integrative bioinformatics tools. Methods: Integrated bioinformatics analyses were performed. One HF dataset (GSE57338) and three PD datasets (GSE7621, GSE20146, GSE49036) were obtained from the GEO database. Weighted gene co-expression network analysis (WGCNA) was used to identify PD-related genes. Differentially expressed genes (DEGs) between PD and normal samples, as well as between HF and normal samples, were identified. The intersection of DEGs, WGCNA-derived PD-related genes, and genes encoding known secretory proteins was analyzed to find PD-associated secretory proteins. Immune cell infiltration in HF was assessed using CIBERSORT. Protein-protein interaction (PPI) network analysis was conducted to identify hub genes. Key findings were experimentally validated in an MPTP-induced PD mouse model through behavioral tests, ELISA, and immunohistochemistry. Results: Analysis identified 21 PD-associated secretory proteins. Intersection with HF DEGs revealed 12 common genes, from which 8 functional genes with consistent expression patterns in both conditions were identified. PPI network analysis highlighted three hub genes: Conclusion: These insights highlight the coexistence of PD and HF and suggest new avenues for investigating strategies to prevent HF in PD patients, particularly by exploring the role of Netrin-1 in the heart and its potential for cardioprotection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.